eMedicine Specialties > Infectious Diseases > Bacterial Infections
Relapsing Fever
Updated: Apr 9, 2009
Introduction
Background
Relapsing fever, as the name implies, is characterized by recurrent acute episodes of fever. These are followed by periods of defervescence of increasing duration.
Relapsing fever is a vector-borne infection that is spread by lice (Pediculus humanus) and ticks (Ornithodoros species). The infection is caused by various spirochete species of the Borrelia genus. Spirochetes are a morphologically unique species of bacteria and also cause syphilis, Lyme disease, and leptospirosis.1
Louse-borne relapsing fever (LBRF) is caused by Borrelia recurrentis, while tick-borne relapsing fever (TBRF) is caused by at least 15 different Borrelia species (eg, Borrelia hermsii, Borrelia turicatae, Borrelia parkeri, Borrelia duttonii).
LBRF and TBRF vary significantly in terms of epidemiology. The human body louse transmits B recurrentis, which causes an epidemic form of relapsing fever, while a soft-bodied tick (Ornithodoros) transmits multiple Borrelia species that cause endemic relapsing fever. Unlike hard ticks, Ornithodoros adult ticks are able to live for many years, feed repeatedly on blood meals, lay eggs, and perpetuate their life cycle.2 In addition, Ornithodoros ticks may survive long periods in a fasting state. In fact, Ornithodoros turicata ticks have been known to transmit spirochetes in the laboratory setting after 7 years without a blood meal.2
Humans are the sole host of B recurrentis, while mammals (eg, cattle, pigs, prairie dogs, ground and tree squirrels, chipmunks) and reptiles (lizards, snakes, gopher tortoises) may serve as a reservoir for tick-borne Borrelia species.2
The first reported case of TBRF in the United States was identified in 1905 in New York. The patient had previously traveled to Texas.3 In the United States, where fewer than 30 cases of TBRF are diagnosed each year,4 B hermsii and B turicatae cause most outbreaks. TBRF is reported worldwide.
LBRF is uncommon in the United States but is occasionally observed in travelers returning from endemic regions (see International). The last reported outbreak of LBRF in the United States occurred in 1871.5
Pathophysiology
Spirochetes are wavy filamentous bacteria with one or more flagellae at each end.1 Borrelial spirochetes measure 3-25 μm X 0.2-0.5 μm. In TBRF, the spirochetes are transmitted via the bite of an infected tick, whereas, in LBRF, contact with hemolymph from the human body louse (eg, from scratching-induced louse crushing) is the mode of spirochete transfer.
Most Ornithodoros tick bites occur at night and go unnoticed in most individuals.6 Other described modes of transmission in the literature include blood transfusions, a laboratory worker who was bitten by an infected monkey with gingival bleeding, and intravenous drug use.2 In rare cases, transplacental transmission has been reported.7 The spirochete is not transmitted via aerosol, saliva, urine, feces, or semen.
Spirochetes enter breaks in the skin or mucous membranes, gain access to the vasculature, and disseminate to the spleen, bone marrow, liver, lungs, kidneys, and CNS.
Borrelia species are able to induce cycles of disease by varying antigen expression and by displaying new outer-surface proteins during the disease course. The proteins are named either variable small proteins or variable large proteins and are encoded within plasmid DNA. Alteration of these proteins prevents elimination of the spirochetes by the immune system, leading to recurrent febrile episodes.2 In 2008, Thein et al identified and described the first porin of relapsing fever, Oms38, which is present in the outer membranes of B hermsii, B turicatae, B duttonii, and B recurrentis.8
Recent experiments in mice have shown that interleukin-10 (IL-10) may play a protective role in down-regulating inflammation and spirochete load.9,10 Extraordinarily high serum IL-10 levels have been found in patients with LBRF in whom the disease course is relatively mild.10 Hemorrhage and thrombosis were more commonly observed in IL-10–deficient mice.10
Frequency
United States
TBRF has been reported in 14 states west of the Mississippi river, including Arizona, California, Colorado, Idaho, Kansas, Montana, Nevada, New Mexico, Oklahoma, Oregon, Texas, Utah, Washington, and Wyoming.11 It has also been reported in Ohio. TBRF usually occurs during the summer in people who are on vacation and/or who are traveling to mountainous regions (elevation >8000 ft).11 Cases of TBRF have been reported in persons inhabiting seasonally occupied lake areas and cabins infested with rodents and/or their ticks. During winter, the ticks are attracted to heat and carbon dioxide generated from indoor fires.11
Eleven states are currently required to report TBRF to their local state health departments: Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming.11
International
- TBRF is endemic in Canada (southern portion of British Columbia), Mexico, Central and South America, central Asia, Africa, and the Mediterranean region.
- LBRF is endemic in Ethiopia and Sudan, especially during the rainy season. The disease typically occurs in areas of war, famine, mass migrations, or overcrowding.4 Homeless people in crowded shelters are also at risk of LBRF. In a study of 930 homeless people in Marseilles, France, body lice were found in 22%, and immunoglobulin G (IgG) to B recurrentis was found in 15 individuals.12
Mortality/Morbidity
- In the United States, TBRF carries a low mortality rate. Overall, TBRF carries a mortality rate of less than 2% (in treated patients) to 4-10% (in untreated individuals).13 LBRF carries a higher mortality rate, with a case-fatality rate of 4% (in treated patients) to 40% (in untreated individuals).14 Two species of Borrelia associated with a relatively high rate of relapsing fever–related fatality include B recurrentis (causes LBRF; found in Africa, South America, Europe, and Asia) and B duttoni (causes TBRF; found in East Africa and transmitted by the soft tick Ornithodoros moubata).2
- Natives of areas with LBRF endemicity usually experience a milder form of the disease than visitors.
- Antibiotic treatment of relapsing fever commonly results in Jarisch-Herxheimer reaction (JHR; see Complications). This reaction tends to be more severe in patients with LBRF treated with penicillin. Pretreatment with steroids does not seem to alter this reaction.
- TBRF has been linked to complications during pregnancy, resulting in neonatal death (up to 50%), spontaneous abortion, and premature birth (see Complications).15
Race
Relapsing fever has no racial predilection.
Sex
Relapsing fever has no sexual predilection.
Clinical
History
- The hallmark of both louse-borne relapsing fever (LBRF) and tick-borne relapsing fever (TBRF) is two or more episodes of high fever (usually >39°C), headaches, and myalgias. The clinical manifestations are also similar. The mean incubation time is 7 days (range, 4-18 or more days).16
- Fever occurs in conjunction with spirochetemia. In TBRF, the initial febrile episode lasts an average of 3 days (range, 12 h to 17 d),15 with an average of 7 days between the initial episode and first relapse. In LBRF, the first febrile episode usually lasts longer, 5.5 days on average (range, 4-10 d), with an average of 9 days between the first episode and first relapse. Patients may feel well between episodes, but the febrile periods are characterized by crises marked by labile blood pressures and pulse. The risk of death is greatest during and immediately following the period of hypotension.4
- Other symptoms of relapsing fever include chills, arthralgias, nausea/vomiting, abdominal pain, mental status changes, nonproductive cough, diarrhea, dizziness, neck pain, photophobia, rash, and dysuria.
- LBRF is associated with a higher incidence of jaundice, petechiae, hemoptysis, epistaxis, and CNS involvement.15
- On average, individuals with TBRF experience 3 relapses, while those with LBRF experience only one.4 Fever tends to be milder with relapses, which result from antigenic variation of the spirochete's outer-surface proteins.2
Physical
Findings in patients with relapsing fever include mental status changes, petechiae, hepatosplenomegaly, abdominal tenderness, jaundice, eschars, abnormal lung function, possible neurologic deficits (cranial nerve palsies, focal deficits), conjunctival suffusion, and the ocular findings listed above.4,14
- Petechiae and ecchymoses are more common in patients with LBRF than in those with TBRF.17,18
- The organomegaly and lung and CNS abnormalities are more commonly associated with LBRF, secondary to direct invasion of spirochetes. Rash is reported more often in patients with TBRF.14
Causes
See Background.
More on Relapsing Fever |
Overview: Relapsing Fever |
| Differential Diagnoses & Workup: Relapsing Fever |
| Treatment & Medication: Relapsing Fever |
| Follow-up: Relapsing Fever |
| Multimedia: Relapsing Fever |
| References |
| Next Page » |
References
Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev. Dec 1986;50(4):381-400. [Medline].
Dworkin MS, Schwan TG, Anderson DE Jr, Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am. Sep 2008;22(3):449-68, viii. [Medline].
Wynns HL. The epidemiology of relapsing fever. In: Moulton FR. A Symposium on Relapsing Fever in the Americas. American Association for the Advancement of Science. Washington, DC: 1942:100-5.
Blevins SM, Greenfield RA, Bronze MS. Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease. Cleve Clin J Med. Jul 2008;75(7):521-30. [Medline].
Moursund WH. Historical introduction to the symposium on relapsing fever. In: Moulton FR. A Symposium on Relapsing Fever in the Americas. American Association for the Advancement of Science. Washington, DC: 1942:1-6.
Barbour AG. Microbiology, pathogenesis, and epidemiology of relapsing fever. UpToDate. Available at http://www.uptodate.com/online/content/topic.do?topicKey=tickflea/11713&selectedTitle=2~15&source=search_result#references. Accessed November 25, 2008.
Fuchs PC, Oyama AA. Neonatal relapsing fever due to transplacental transmission of Borrelia. JAMA. Apr 28 1969;208(4):690-2. [Medline].
Thein M, Bunikis I, Denker K, Larsson C, Cutler S, Drancourt M, et al. Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes. J Bacteriol. Nov 2008;190(21):7035-42. [Medline].
Gelderblom H, Schmidt J, Londoño D, Bai Y, Quandt J, Hornung R, et al. Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol. Jan 2007;170(1):251-62. [Medline].
Londoño D, Marques A, Hornung RL, Cadavid D. Relapsing fever borreliosis in interleukin-10-deficient mice. Infect Immun. Dec 2008;76(12):5508-13. [Medline].
Centers for Disease Control and Prevention (CDC). Acute respiratory distress syndrome in persons with tickborne relapsing fever--three states, 2004-2005. MMWR Morb Mortal Wkly Rep. Oct 19 2007;56(41):1073-6. [Medline].
Brouqui P, Stein A, Dupont HT, Gallian P, Badiaga S, Rolain JM, et al. Ectoparasitism and vector-borne diseases in 930 homeless people from Marseilles. Medicine (Baltimore). Jan 2005;84(1):61-8. [Medline].
Barbour AG. Clinical features and management of relapsing fever. UpToDate. Available at http://www.uptodate.com/online/content/topic.do?topicKey=tickflea/11413#1. Accessed November 25, 2008.
Rhee KY, Johnson WD Jr. Borrelia species (relapsing fever). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Vol 2. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005:2795-8.
Goubau PF. Relapsing fevers. A review. Ann Soc Belg Med Trop. 1984;64(4):335-64. [Medline].
Southern PM, Sanford JP. Relapsing fever: a clinical and microbiological review. Medicine. 1969;48:129-49.
Perine PL, Parry EH, Vukotich D, Warrell DA, Bryceson AD. Bleeding in louse-borne relapsing fever. I. Clinical studies in 37 patients. Trans R Soc Trop Med Hyg. 1971;65(6):776-81. [Medline].
Dennis DT, Awoke S, Doberstyn EB, Fresh JW. Bleeding in louse-borne relapsing fever in Ethiopia; clinical and laboratory features in 29 patients. East Afr Med J. Apr 1976;53(4):220-5. [Medline].
Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis. Mar 15 2001;32(6):897-928. [Medline].
van Dam AP, van Gool T, Wetsteyn JC. Tick-borne relapsing fever imported from West Africa: diagnosis by quantitative buffy coat analysis and in vitro culture of Borrelia crocidurae. J Clin Microbiol. Jun 1999;37(6):2027-30. [Medline].
Kelly R. Cultivation of Borrelia hermsi. Science. Jul 30 1971;173(995):443-4. [Medline].
Schwan TG, Gage KL, Karstens RH, Schrumpf ME, Hayes SF, Barbour AG. Identification of the tick-borne relapsing fever spirochete Borrelia hermsii by using a species-specific monoclonal antibody. J Clin Microbiol. Apr 1992;30(4):790-5. [Medline].
Fukunaga M, Okada K, Nakao M, Konishi T, Sato Y. Phylogenetic analysis of Borrelia species based on flagellin gene sequences and its application for molecular typing of Lyme disease borreliae. Int J Syst Bacteriol. Oct 1996;46(4):898-905. [Medline].
Jiang J, Temenak JJ, Richards AL. Real-time PCR duplex assay for Rickettsia prowazekii and Borrelia recurrentis. Ann N Y Acad Sci. Jun 2003;990:302-10. [Medline].
Magnarelli LA, Anderson JF, Johnson RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis. Jul 1987;156(1):183-8. [Medline].
Magnarelli LA, Meegan JM, Anderson JF, Chappell WA. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol. Aug 1984;20(2):181-4. [Medline].
Hasin T, Davidovitch N, Cohen R, Dagan T, Romem A, Orr N, et al. Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever. N Engl J Med. Jul 13 2006;355(2):148-55. [Medline].
Dworkin MS, Anderson DE Jr, Schwan TG. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis. Jan 1998;26(1):122-31. [Medline].
Scott R. Neurological complications of relapsing fever. Lancet. 1944;247:436-8.
Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis. Jan 1998;26(1):151-64. [Medline].
Wengrower D, Knobler H, Gillis S, Chajek-Shaul T. Myocarditis in tick-borne relapsing fever. J Infect Dis. Jun 1984;149(6):1033. [Medline].
Further Reading
Keywords
relapsing fever, louse-borne relapsing fever, LBRF, tick-borne relapsing fever, TBRF, human body louse, Pediculus humanus, soft-bodied ticks, Ornithodoros species, species, Borrelia recurrentis, Borrelia turicatae, Borrelia hermsii, Borrelia parkeri, Borrelia duttonii, B recurrentis, B turicatae, B hermsii, B parkeri, B duttonii
Overview: Relapsing Fever